Octohydroaminoacridine succinate tablet

octohydroaminoacridine succinate · Shanghai Mental Health Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Octohydroaminoacridine succinate tablet, covering 2019-10-22 to 2019-10-22. Get the full timeline:

Most recent: Clinical Trial Update: Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease [Phase 3]